SYNOLACTATE-PLUS cross-sectional study: prospective validation of RESAS and synovial biomarkers in septic arthritis diagnosis.

Berthoud O, Bendavid C, Boguenet A, Albert JD, Bart G, Guggenbuhl P, Coiffier G, Robin F

Open source

DOI
10.1007/s10067-026-08432-0
Published
2026 Sep 23
Container
Clinical rheumatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10067-026-08432-0,
  title = {SYNOLACTATE-PLUS cross-sectional study: prospective validation of RESAS and synovial biomarkers in septic arthritis diagnosis.},
  author = {Berthoud O and Bendavid C and Boguenet A and Albert JD and Bart G and Guggenbuhl P and Coiffier G and Robin F},
  year = {2026},
  journal = {Clinical rheumatology},
  doi = {10.1007/s10067-026-08432-0},
  url = {https://doi.org/10.1007/s10067-026-08432-0}
}

RIS

TY  - JOUR
TI  - SYNOLACTATE-PLUS cross-sectional study: prospective validation of RESAS and synovial biomarkers in septic arthritis diagnosis.
AU  - Berthoud O
AU  - Bendavid C
AU  - Boguenet A
AU  - Albert JD
AU  - Bart G
AU  - Guggenbuhl P
AU  - Coiffier G
AU  - Robin F
PY  - 2026
JO  - Clinical rheumatology
DO  - 10.1007/s10067-026-08432-0
UR  - https://doi.org/10.1007/s10067-026-08432-0
ER  - 

APA

O, B., C, B., A, B., JD, A., G, B., P, G., G, C., & F, R. (2026). SYNOLACTATE-PLUS cross-sectional study: prospective validation of RESAS and synovial biomarkers in septic arthritis diagnosis.. Clinical rheumatology. https://doi.org/10.1007/s10067-026-08432-0

Source records